v3.24.3
Collaboration agreements - Johnson & Johnson (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2022
USD ($)
target
performanceObligation
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Collaboration agreements              
Collaboration revenue   $ 12,598 $ 7,698 $ 24,136 $ 26,154    
Deferred revenue   115,237 133,096 115,237 133,096 $ 125,314 $ 147,653
Johnson & Johnson Agreement              
Collaboration agreements              
Number of targets designated | target 3            
Upfront payment received $ 40,000            
Performance obligations identified | performanceObligation 7            
Revised transaction price   56,000   56,000      
Johnson & Johnson Agreement | Performance obligations              
Collaboration agreements              
Collaboration revenue   8,400 $ 4,900 16,300 14,000    
Johnson & Johnson Agreement | Development milestone achieved              
Collaboration agreements              
Collaboration revenue       8,000 $ 2,000    
Johnson and Johnson 2024 CMC Arrangement              
Collaboration agreements              
Revised transaction price   8,500   8,500      
Collaboration revenue   400   400      
Johnson and Johnson Agreement and Johnson and Johnson 2024 CSA Arrangement              
Collaboration agreements              
Deferred revenue   $ 6,600   $ 6,600   $ 10,400